NotCo's vegan chicken is now on the menu of two new Burger King sandwiches and nuggets across locations in Chile.
Burger King says the growing demand for vegan options has made the partnership with NotCo, which debuted its vegan chicken last year, an easy decision.
NotCo has previously worked with Burger King on menu items in Chile and Paraguay.
The chicken's launching comes at the same time as Burger King is temporarily eliminating meat from its entire menu at two of its outlets in Chile. It has already been done by the fast food company, most recently in Europe at two sites in Switzerland. That came after its flagship London branch made a vegan change.
Similar to Impossible Foods, Burger King's most notable North American partner, NotCo is gaining consumer brand recognition to boost demand for vegan menu items.
Since NotCo, a Chilean food-tech business known for its Giusseppe AI technology raised $235 million in a Series D fundraising round with contributions from Lewis Hamilton, Roger Federer, and Oscar-winning singer and director Questlove, it's been a busy year.
With the capital from the previous year, NotCo entered the unicorn realm and received a $1.5 billion valuation, a first for a Chilean company. Only a year earlier, the business had a $250 million valuation. Matias Muchnick founded NotCo in 2015 to advance plant-based diets both in its home market of Latin America and throughout the rest of the world.
This spring, NotCo increased its market share in the US by teaming up with Shake Shack to create a dairy-free milkshake. With its NotBurgers, it expanded its influence in Canada as well.
NotCo and Kraft Heinz have created a new joint venture to develop plant-based products.


Why a ‘rip-off’ degree might be worth the money after all – research study
The pandemic is still disrupting young people’s careers
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Airbus Joins Air India A320 Altitude Drop Probe
Oil Prices Rise as US-Iran Talks Stall, Inflation Risks Grow
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
BOJ Signals Faster Rate Hikes as Inflation Risks Raise September Move Odds
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 



